BNGO Bionano Company Cash Volume

Official company branding of bionanogenomics.com (BNGO)

Bionano Genomics, Inc. (BNGO) efforts to establish OGM as the cytogenetics standard are reflected in its liquidity dynamics. The volume of highly liquid cash assets demonstrates a financial foundation, where the metric value stands at 0.01. The company is implementing energy-efficient IT solutions for data protection, while the growing number of Saphyr installations creates a tangible operational effect as the market awaits the expansion of insurance reimbursements.

Company Liquid Assets: Bionano Genomics (BNGO) for 07/04/2022 - 11/21/2026

Analytical breakdowns and data insights for company bionanogenomics.com (BNGO)

- stock quotes and analyst forecast:
- cash balance and cash flow data:
Summary company analytics:Bionano Genomics, Inc.
Brand item of Bionano Genomics, Inc.

This indicator reflects the total volume of liquid assets available for operational management without the need for external financing. The metric allows for an assessment of financial resilience and the risk of operational cessation in the event of a funding deficit. For Bionano Genomics, Inc. (BNGO), whose R&D expenses exceed revenues, this balance is critically important. Chronic negative cash flow makes the company dependent on reserves. By analyzing cash capital dynamics, an investor determines the business's actual runway.

Competitors of Bionano Genomics, Inc.

Company Cash Volume TEM|QGEN - Company Cash Reserve|ionispharma.com - Company Cash on Hand|Company Cash Balance RGEN|Avidity Corp - Company Cash Volume|CRISPR Therapeutics Corp - Company Total Cash Amount|GeneDx Holdings (WGS) - Company Cash Funds|Ultragenyx Pharmaceutical (RARE) - Company Cash Volume|Company Cash on Hand BEAM|Sarepta (SRPT) - Company Liquid Assets|Company Cash Funds Twist Bioscience Corp (TWST)|10x - Company Cash and Cash Equivalents|Company Cash Volume NTLA (intelliatx.com)|Company Total Cash Amount STOK (stoketherapeutics.com)|BioLife Solutions Inc - Company Cash Volume|WVE (Wave Life Sciences Ltd) - Company Cash and Cash Equivalents|Maze Therapeutics Corp (MAZE) - Company Cash Funds|Company Cash and Cash Equivalents SION|PRME (Prime Medicine Inc) - Company Cash Volume|Taysha Gene Therapies (TSHA) - Company Liquid Assets|Company Cash on Hand QURE (uniqure.com)|Company Total Cash Amount MGTX|Company Cash Volume RGNX (regenxbio.com)|SLDB: Company Cash and Cash Equivalents|ocugen.com - Company Cash Volume|PACB - Company Cash Volume|BNTC: Company Cash Volume|Company Cash and Cash Equivalents DSGN|Company Cash Funds Rocket Pharmaceuticals|Company Cash on Hand 4DMT (FDMT)|Company Cash Volume LXEO|Company Liquid Assets Korro Bio Inc.|Company Cash Volume EDIT (Editas Medicine Inc)|SLN: Company Cash and Cash Equivalents|PRQR - Company Cash Funds|Company Liquid Assets codexis.com CDXS|SGMO: Company Cash Volume|Nautilus Biotechnology (NAUT) - Company Cash Volume|Company Cash Funds Metagenomi, Inc|precisionbiosciences.com (DTIL) - Company Liquid Assets|Company Cash Funds Generation Bio Co. (GBIO)|Company Liquid Assets Boundless Bio, Inc.|Company Cash Funds Exicure, Inc. XCUR|IMNN: Company Cash and Cash Equivalents|PHIO - Company Cash Funds|Company Liquid Assets Mustang Bio MBIO|RNAZ: Company Cash Volume|Company Cash and Cash Equivalents APDN|BLUE (bluebirdbio.com) - Company Cash Volume|Company Cash Reserve ImmunoPrecise Antibodies IPA|Company Cash on Hand OMGA (omegatherapeutics.com)|Company Cash Volume Singular Genomics Systems, Inc. (OMIC)|Company Cash Volume RGLS (Regulus Therapeutics, Inc.)|Company Cash Volume Syros SYRS|Telesis Bio, Inc. - Company Cash Volume|TRACON Pharmaceuticals (TCON) - Company Cash on Hand|UBX: Company Cash Volume